Kiniksa Pharmaceuticals International Plc (KNSA)
49.35
+0.65
(+1.33%)
USD |
NASDAQ |
Jun 10, 16:00
49.35
0.00 (0.00%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International SG&A Expense (Quarterly) : 61.15M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 61.15M |
| December 31, 2025 | 56.78M |
| September 30, 2025 | 49.10M |
| June 30, 2025 | 46.86M |
| March 31, 2025 | 43.53M |
| December 31, 2024 | 40.54M |
| September 30, 2024 | 46.40M |
| June 30, 2024 | 42.40M |
| March 31, 2024 | 38.68M |
| December 31, 2023 | 36.74M |
| September 30, 2023 | 34.47M |
| June 30, 2023 | 29.18M |
| March 31, 2023 | 29.04M |
| December 31, 2022 | 27.22M |
| September 30, 2022 | 24.68M |
| June 30, 2022 | 23.84M |
| March 31, 2022 | 22.22M |
| December 31, 2021 | 22.74M |
| September 30, 2021 | 20.76M |
| Date | Value |
|---|---|
| June 30, 2021 | 21.85M |
| March 31, 2021 | 20.60M |
| December 31, 2020 | 15.50M |
| September 30, 2020 | 11.80M |
| June 30, 2020 | 9.536M |
| March 31, 2020 | 8.486M |
| December 31, 2019 | 9.695M |
| September 30, 2019 | 8.432M |
| June 30, 2019 | 8.441M |
| March 31, 2019 | 8.394M |
| December 31, 2018 | 8.013M |
| September 30, 2018 | 5.515M |
| June 30, 2018 | 4.327M |
| March 31, 2018 | 3.71M |
| December 31, 2017 | 2.78M |
| September 30, 2017 | 2.241M |
| June 30, 2017 | 2.12M |
| March 31, 2017 | 1.903M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Autolus Therapeutics Plc | 39.89M |
| Barinthus Biotherapeutics Plc | 2.524M |
| Aurinia Pharmaceuticals, Inc. | 22.03M |
| Adaptimmune Therapeutics Plc | 18.71M |
| Aptorum Group Ltd. | 0.2117M |